Cardiac Valve Diseases And Treatments
26 researchers across 3 institutions
Research in cardiac valve diseases and treatments investigates the causes, progression, and therapeutic strategies for conditions affecting the heart's valves. This area encompasses studies on the cellular and molecular mechanisms underlying valve dysfunction, including the development of fibrosis, calcification, and degeneration. Researchers employ a range of methodologies, from laboratory-based investigations using cell cultures and animal models to clinical studies analyzing patient outcomes and exploring novel diagnostic and interventional approaches. Specific interests include understanding the genetic and environmental factors that contribute to valve disease, evaluating the efficacy of existing medical and surgical treatments, and developing new technologies for valve repair and replacement.
This work holds particular relevance for Arkansas, a state facing significant cardiovascular health challenges. Understanding the prevalence and specific risk factors for cardiac valve diseases within the state's population can inform public health initiatives and targeted interventions. Research into less invasive treatment options and advanced prosthetic devices can contribute to improved patient care and potentially foster innovation in the state's growing medical technology sector. Furthermore, insights gained from this research can help address disparities in cardiovascular care that may exist within Arkansas.
This research area benefits from extensive interdisciplinary collaboration, drawing upon expertise in cardiovascular function, medical imaging, congenital heart disease, and surgical techniques. Engagement extends across multiple Arkansas institutions, fostering a comprehensive approach to understanding and treating cardiac valve diseases.
Top Researchers
| Name | Institution | h-index | Citations | Career Stage | Badges |
|---|---|---|---|---|---|
| Neil B. Ingels | University of Arkansas | 52 | 8,702 | High Impact | |
| Kartik Balachandran | University of Arkansas | 26 | 2,748 | Grant PI High Impact | |
| Morten Ø. Jensen | University of Arkansas | 19 | 1,547 | ARA Grant PI | |
| Brian Reemtsen | UAMS | 18 | 1,438 | ||
| M. Henry | UAMS | 16 | 1,041 | ||
| Hani Alturkmani | UAMS | 10 | 411 | ||
| Ishita Tandon | University of Arkansas | 9 | 299 | ||
| Khalid Sawalha | UAMS | 7 | 347 | ||
| Taufiek Konrad Rajab | UAMS | 7 | 227 | ||
| Sam E. Stephens | University of Arkansas | 6 | 75 | ||
| Ahmed Negm | UAMS | 5 | 57 | ||
| Lawrence Greiten | UAMS | 4 | 67 | ||
| Haytham Alkhaimy | UAMS | 4 | 52 | ||
| Alexis P. Applequist | University of Arkansas | 3 | 23 | ||
| Thomas Heye | UAMS | 3 | 24 | ||
| Naga Sai Shravan Turaga | UAMS | 3 | 15 | ||
| Gustavo Vaca-Diez | University of Arkansas | 2 | 39 | ||
| Patrick Kuczwara | University of Arkansas | 2 | 26 | ||
| Navya Nalajala | UAMS | 2 | 19 | ||
| Ahmed Zaghw | UAMS | 2 | 19 |
Related Research Areas
Connected Research Areas
Topics that share active collaborators with Cardiac Valve Diseases And Treatments in Arkansas. Pairs are ranked by collaboration density relative to expected co-authorship under a random null. This describes existing connections, not investment recommendations.
- Cardiovascular Function and Risk Factors
- Tissue Engineering and Regenerative Medicine
- Mechanical Circulatory Support Devices
- Atrial Fibrillation Management and Outcomes
- Medical Imaging Techniques and Applications
- Extracellular vesicles in disease
- Health Literacy and Information Accessibility
- Innovations in Medical Education
Strategic Outlook
Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW
Top US institutions in this area
- 1 Cleveland Clinic 4,097
- 2 Harvard University 3,499
- 3 Mayo Clinic 3,457
- 4 Mayo Clinic in Arizona 2,504
- 5 Massachusetts General Hospital 2,311
Cross-Institution Connections
Researchers at different institutions with overlapping expertise in Cardiac Valve Diseases And Treatments.